ALFA Filings
Every announcement, straight from the exchange
Every Cohance Lifesciences management change announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Cohance Lifesciences appointed Mr. Abhimanyu Ojha as the new Chief Financial Officer and Key Managerial Personnel, effective October 12, 2026.
Cohance Lifesciences Limited has appointed Mr. Umang Vohra as Chairman effective May 1, 2026. This follows the resignation of Mr. Vivek Sharma as Executive Chairman on April 30, 2026, due to personal reasons. Mr. Vohra brings over 30 years of experience, including leadership roles at Cipla and Dr. Reddy's.
Cohance Lifesciences Limited has appointed Mr. Umang Vohra as Chairman and Group CEO. Mr. Vohra brings over 30 years of experience, including leadership roles at Cipla, Dr. Reddy's Laboratories, and PepsiCo India.
Cohance Lifesciences appointed Umang Vohra as Executive Chairman (effective May 1, 2026) and Group CEO (effective May 20, 2026). He succeeds Vivek Sharma, who is stepping down for personal reasons but will remain as an advisor for nine months to ensure a smooth transition. Mr. Vohra previously served as MD and CEO of Cipla.